Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain H Rook

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Journal of the American Academy of Dermatology|October 5, 2010
A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasisAlain H Rook, Gary S Wood, Madeleine Duvic, et al.
Journal of the American Academy of Dermatology|October 19, 2011
Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndromeArielle R Nagler, Sara Samimi, Andras Schaffer, et al.
Journal of the American Academy of Dermatology|August 23, 2005
Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndromeCamille E Introcaso, Stephen D Hess, Malek Kamoun, et al.
Archives of Dermatology|August 18, 2010
Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppressionSara Samimi, Bernice Benoit, Katherine Evans, et al.
Blood|April 18, 2022
Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphomaSara Beygi, George E Duran, Sebastian Fernandez-Pol, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanismsKaren S McGinnis, Jacqueline M Junkins-Hopkins, Glen Crawford, et al.
Cancer Research|March 26, 2009
In vivo imaging of cutaneous T-cell lymphoma migration to the skinChristoph Hoeller, Stephen K Richardson, Lai Guan Ng, et al.
Journal of the American Academy of Dermatology|December 1, 2009
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphomaRachel H Gormley, Stephen D Hess, Dipti Anand, et al.
Journal of the American Academy of Dermatology|June 23, 2009
A novel regimen of vorinostat with interferon gamma for refractory Sézary syndromeJennifer M Gardner, Camille E Introcaso, Sunita D Nasta, et al.
Journal of the American Academy of Dermatology|February 15, 2011
Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sézary syndromeKatherine G Evans, Andrea B Troxel, Barbara J DeNardo, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Journal of the American Academy of Dermatology|October 5, 2010
A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasisAlain H Rook, Gary S Wood, Madeleine Duvic, et al.
Journal of the American Academy of Dermatology|October 19, 2011
Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndromeArielle R Nagler, Sara Samimi, Andras Schaffer, et al.
Journal of the American Academy of Dermatology|August 23, 2005
Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndromeCamille E Introcaso, Stephen D Hess, Malek Kamoun, et al.
Archives of Dermatology|August 18, 2010
Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppressionSara Samimi, Bernice Benoit, Katherine Evans, et al.
Blood|April 18, 2022
Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphomaSara Beygi, George E Duran, Sebastian Fernandez-Pol, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanismsKaren S McGinnis, Jacqueline M Junkins-Hopkins, Glen Crawford, et al.
Cancer Research|March 26, 2009
In vivo imaging of cutaneous T-cell lymphoma migration to the skinChristoph Hoeller, Stephen K Richardson, Lai Guan Ng, et al.
Journal of the American Academy of Dermatology|December 1, 2009
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphomaRachel H Gormley, Stephen D Hess, Dipti Anand, et al.
Journal of the American Academy of Dermatology|June 23, 2009
A novel regimen of vorinostat with interferon gamma for refractory Sézary syndromeJennifer M Gardner, Camille E Introcaso, Sunita D Nasta, et al.
Journal of the American Academy of Dermatology|February 15, 2011
Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sézary syndromeKatherine G Evans, Andrea B Troxel, Barbara J DeNardo, et al.
Pageof 10